Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Amgen develops PET probe for cytotoxic lymphocyte detection for cancer immunotherapy

June 23, 2017

FDA gives orphan drug designation to pamrevlumab for pancreatic cancer

June 22, 2017

Infuseon and OncoSynergy partner to test OS-2966 with Cleveland Multiport Catheter in glioblastoma

June 22, 2017

GlaxoSmithKline describes novel hSTING modulators

June 22, 2017

Janssen enters agreement to use Adaptive Biotechnologies' assay in daratumumab studies

June 22, 2017

Anti-KIR3DL2 monoclonal antibody IPH-4102 receives U.S. orphan designation

June 22, 2017

Leap Therapeutics to collaborate with Merck for evaluation of Keytruda in combination with DKN-01

June 22, 2017

Seattle Genetics submits supplemental BLA for Adcetris in CTCL

June 21, 2017

Heidelberg Pharma and Takeda sign exclusive multitarget research agreement

June 21, 2017

Enrollment to begin in phase I/II trial of Ceplene for the treatment of CMML

June 21, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...